Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

BiondVax Pharmaceuticals Ltd ADR

BVXV
Current price
0.69 USD +0.05 USD (+7.81%)
Last closed 0.7 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 4 966 625 USD
Yield for 12 month -93.04 %
Week
Month
Year
BVXV
21.11.2021 - 28.11.2021

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel. Address: Jerusalem BioPark Building, Jerusalem, Israel

Analytics

WallStreet Target Price

39 USD

P/E ratio

Dividend Yield

Current Year

Last Year

+2 748 000 USD

Current Quarter

Last Quarter

+2 016 000 USD

Current Year

Last Year

+2 748 000 USD

Current Quarter

Last Quarter

+2 016 000 USD

Key Figures BVXV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -10 396 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -30.89 %
PEG Ratio
Return On Equity TTM -5601.53 %
Wall Street Target Price 39 USD
Revenue TTM
Book Value -1.96 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -2.35 USD
Diluted Eps TTM -2.35 USD
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BVXV

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BVXV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 25.11.2022
Dividend Date

Stock Valuation BVXV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -2.0671
Price Book MRQ 7.4836

Financials BVXV

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators BVXV

For 52 weeks

0.62 USD 11.49 USD
50 Day MA 1.17 USD
Shares Short Prior Month 3 617
200 Day MA 1.79 USD
Short Ratio 0.32
Shares Short 4 883
Short Percent 0.15 %